Want to join the conversation?
$PNR expects 2016 core sales to fall about 1%. Segment income is expected to grow roughly 9% and return on sales to expand about 90 BP to 16.5%. Corporate cost is expected to be about $90MM, net interest and other about $140MM and share count about 182MM. Free cash flow is expected to be about $750MM, about 100% of adjusted net income.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?